ANAPTYSBIO, INC Common Stock Shares Outstanding

• ANAPTYSBIO, INC showed a decrease of -8.1% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from ANAPTYSBIO, INC's annual report (Form 10-K), filed with the SEC on March 3, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2017: 20.25 million shares | Q2 2017: 20.29 million shares | Q3 2017: 20.50 million shares | Q1 2018: 23.82 million shares | Q2 2018: 24.03 million shares | Q3 2018: 26.75 million shares | Q1 2019: 27.01 million shares | Q2 2019: 27.04 million shares | Q3 2019: 27.10 million shares | Q1 2020: 27.28 million shares | Q2 2020: 27.29 million shares | Q3 2020: 27.35 million shares | Q1 2021: 27.37 million shares | Q2 2021: 27.43 million shares | Q3 2021: 27.45 million shares | Q1 2022: 28.18 million shares | Q2 2022: 28.23 million shares | Q3 2022: 28.35 million shares | Q1 2023: 27.02 million shares | Q2 2023: 26.53 million shares | Q3 2023: 26.58 million shares | Q1 2024: 27.32 million shares | Q2 2024: 27.43 million shares | Q3 2024: 30.43 million shares | Q1 2025: 30.39 million shares | Q2 2025: 27.97 million shares | Q3 2025: 27.58 million shares.
• Over the full 10 years of available data (2016 to 2025), ANAPTYSBIO, INC's Common Stock Shares Outstanding has grown by 956.9%.
• Historical annual values: Fiscal year 2025: 28.02 million shares | Fiscal year 2024: 30.47 million shares | Fiscal year 2023: 26.60 million shares | Fiscal year 2022: 28.51 million shares | Fiscal year 2021: 27.65 million shares | Fiscal year 2020: 27.36 million shares | Fiscal year 2019: 27.26 million shares | Fiscal year 2018: 26.92 million shares | Fiscal year 2017: 23.79 million shares | Fiscal year 2016: 2.65 million shares.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026